Changes in NAWM and NAGM are crucial in MS progression, challenging the traditional lesion-centric model. Subtle alterations in myelin integrity, immune cell function, and neuronal connectivity ...

Several factors were associated with increased pain among patients with systemic sclerosis, including the pain type, pain location, and disease subtype. Nearly all patients with systemic sclerosis ...

Investigational interstitial lung disease (ILD) drug, efzofitimod, shows early signs of efficacy in patients with pulmonary sarcoidosis and SSc-ILD (scleroderma-related ILD), according to new trial ...

Please provide your email address to receive an email when new articles are posted on . Mycophenolate mofetil outperformed methotrexate, steroids and other immunosuppressives in diffuse cutaneous SSc ...

The following is a summary of “Cardiogenic shock in systemic sclerosis: a retrospective study of acute ventricular dysfunction,” published in the April 2025 issue of Rheumatology International by ...

Scleroderma, or systemic sclerosis refers to a disorder in which the skin and connective tissues of the body start to thicken and harden because of the overproduction of a protein called collagen.

Delayed esophageal transit on scintigraphy in patients with systemic sclerosis was linked to diffuse cutaneous disease, advanced lung involvement, and severe diarrhea. Delayed esophageal transit on ...